ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 84 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,100,000 | -8.3% | 647,008 | +11.1% | 0.01% | 0.0% |
| Q1 2022 | $1,200,000 | -43.4% | 582,508 | +3.1% | 0.01% | -37.5% |
| Q4 2021 | $2,120,000 | +438.1% | 565,208 | +640.8% | 0.01% | +300.0% |
| Q3 2021 | $394,000 | -95.5% | 76,300 | -96.3% | 0.00% | -94.9% |
| Q2 2021 | $8,772,000 | -16.5% | 2,059,092 | +4.1% | 0.04% | -20.4% |
| Q1 2021 | $10,504,000 | +11.4% | 1,978,234 | +13.0% | 0.05% | +6.5% |
| Q4 2020 | $9,433,000 | +131.9% | 1,750,000 | +483.3% | 0.05% | +170.6% |
| Q3 2018 | $4,068,000 | +528.7% | 300,000 | +209.6% | 0.02% | +466.7% |
| Q4 2017 | $647,000 | -73.6% | 96,900 | -82.2% | 0.00% | -78.6% |
| Q2 2017 | $2,449,000 | -15.1% | 545,500 | +4.2% | 0.01% | -12.5% |
| Q1 2017 | $2,883,000 | +83.6% | 523,300 | +301.9% | 0.02% | +23.1% |
| Q4 2015 | $1,570,000 | – | 130,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Matrix Capital Management Company, LP | 38,974,185 | $166,030,000 | 1.81% |
| Endurant Capital Management LP | 1,539,435 | $6,558,000 | 1.80% |
| NEA Management Company, LLC | 17,082,611 | $72,772,000 | 0.95% |
| PFM Health Sciences, LP | 3,627,900 | $15,455,000 | 0.48% |
| GSA CAPITAL PARTNERS LLP | 513,388 | $2,187,000 | 0.25% |
| Baker Brothers Advisors | 9,830,877 | $41,880,000 | 0.18% |
| Avoro Capital Advisors LLC | 2,024,400 | $8,624,000 | 0.15% |
| Vigilare Wealth Management | 54,250 | $231,000 | 0.14% |
| AlphaCentric Advisors LLC | 120,000 | $511,000 | 0.14% |
| Rock Springs Capital Management LP | 1,545,000 | $6,582,000 | 0.13% |